Additionally, combining a CSF-1R signaling antagonist with paclitaxel has been shown to enhance the survival of mice with mammary tumors by slowing primary tumor growth and reducing pulmonary metastasis [160]. This evidence concerns the gene CSF1R and neoplasm.